# Eli Lilly’s Weight-Loss Drug Shows Promising Results in Lowering Diabetes Risk – In a recent three-year trial, Eli Lilly’s weight-loss drug has shown to reduce the risk of developing diabetes by an impressive 94%. – The study involved participants who were overweight or obese and had prediabetes, a condition that often leads to developing type 2 diabetes. – Along with weight loss, participants experienced improvements in other metabolic markers, such as blood pressure and cholesterol levels. – These results offer hope for individuals looking to manage their weight and reduce their risk of developing diabetes. ### Eli Lilly’s commitment to developing effective weight-loss solutions is evident in the success of their new drug. With proper guidance and support, individuals can enhance their overall health and well-being by incorporating this innovative treatment into their weight loss journey. Contact Mindful Evolution today to learn more about how we can support you in achieving your weight loss goals in a safe and sustainable manner. Weight Loss Disclaimer: Individual results may vary. Mindful Evolution offers telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia.